United States

Federal One Health coordination spans the CDC, USDA, and EPA, with active current attention on H5N1 surveillance in dairy cattle and poultry, and longstanding work on antimicrobial resistance in agriculture.

Chronic disease, behavioral health, and maternal health disparities across geography and income represent the dominant domestic burden, alongside persistent rural hospital closures constraining care access.

A fragmented, predominantly private insurance-based system with significant public programs for older adults and low-income populations, producing wide variation in access and outcomes by state and income.

Wildfire smoke exposure, extreme heat, and water infrastructure aging are growing environmental health concerns, disproportionately affecting lower-income and rural communities.

A highly developed commercial veterinary and biosecurity system exists alongside real surveillance gaps in the informal spread of pathogens like H5N1 across dairy operations, where testing has been inconsistent.

Extreme heat, wildfire smoke, and increasingly severe hurricane and flooding events are placing growing strain on health infrastructure, particularly in the Gulf Coast, Southwest, and Western states.

The United States retains the world's most significant biomedical research and vaccine manufacturing base, though domestic public health workforce capacity has not fully recovered from pandemic-era attrition.

Federal health policy priorities are in active flux, with ongoing debate over public health agency funding, vaccine policy, and the future structure of international health engagement.

The United States remains one of the largest bilateral global health funders in absolute terms, even as recent shifts in foreign assistance policy have introduced significant uncertainty into multi-year program financing abroad.

USAID historically, the CDC, the NIH, and major domestic foundations have anchored U.S. global health engagement, alongside private philanthropic capital increasingly filling gaps left by contracting federal assistance.

The gap between the country's world-leading biomedical research capacity and its comparatively weak primary care and public health infrastructure is a long-documented and still unresolved structural weakness.

The U.S. story is less about resource scarcity than about coordination: enormous capacity exists, but rarely in the places, or across the sectors, where it would do the most good.